Skip to content
zameds

Diaran Mr

Gliclazide

S3Read from the PI-PIL document and verified
Loading the molecular structure
C15H21N3O3S323.40 g/mol

1-(3,3a,4,5,6,6a-Hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 3475.

Registration

Applicants
2
Registrations
2
Schedule source
SAHPRA documentation

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) LtdCancelledDiaran mr30 mg410698S3PIPIL
Ranbaxy (SA) (Pty) LtdDiaran mr60490926.927S3None

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Diaran mr 30

EACH TABLET CONTAINS GLICLAZIDE 30,0 mg

30 mg.Modified release tablets41069841/21.2/0698Approved 30 November 2022CancelledS3PIPIL
Diaran mr 60

Each Tablet contains: Gliclazide 60,0 mg

60490926.92749/21.2/0926.927RegisteredS3None

Regulatory status

Where S3 sits on the scale

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Gliclazide

  • S3: Gliclazide

    Consolidated Schedules 06 July 2026, line 3675

Pharmacological class: Oral hypoglycaemics. (class 21.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Diaran mr 30, Ranbaxy Pharmaceutical (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles